We are thrilled to invite you to the Global Conference on Endocrinology, Metabolism, and Molecular Medicine, organized by the United Research Forum. This distinguished event, scheduled for July 15-16, 2025, in the vibrant city of Berlin, Germany, promises to be a premier gathering for professionals across the field.
The conference aims to foster collaboration and knowledge exchange among researchers, clinicians, and industry experts by providing a platform to discuss the latest advancements and research in endocrinology, metabolism, and molecular medicine.The program will include keynote addresses from leading experts on groundbreaking research and innovations. Attendees will benefit from a rich scientific agenda that covers a wide array of topics, including the latest in hormone regulation, metabolic disease management, and molecular diagnostic techniques. In addition to keynote speeches, the conference will feature plenary sessions, panel discussions, oral and poster presentations, and interactive workshops.
These sessions will allow for in-depth exploration of new research findings, case studies, and cutting-edge treatment strategies. Topics of discussion will include advancements in endocrine and metabolic disorders, the role of molecular medicine in disease management, and the integration of novel therapeutic approaches. This comprehensive program will ensure a thorough understanding of current trends and future directions in the field, fostering an environment of learning and professional growth.
We sincerely hope that many key stakeholders in long-term health will join us for this exceptional event. We are eagerly looking forward to welcoming you to the GEMM-2025 conference in Berlin, Germany.
For further information, please contact the conference organizer at:
Sarah Jones
Tel: +44 7867 919466
Email: [email protected]
Adrenal Disorders: From Adrenarche to Adrenopause |
Artificial Intelligence: The Future for Diabetes Care |
Bone Health and Osteoporosis |
Cardiovascular Endocrinology |
Case Reports : Diabetes |
Clinical Endocrinology |
COVID-19 Impacts in People with Diabetes |
Diabetes and Glucose Metabolism |
Diabetes and Hypoglycemiea |
Diabetes and Hypoglycemiea |
Diabetic Nephropathy |
Diabetic Retinopathy |
Diastrophic dysplasia |
Endocrine Disrupting Chemicals |
Endocrine Neoplasia and Cancer |
Endocrine Tumor Syndromes |
Genomics in Endocrinology |
Gestational Diabetes |
Health Equity and Access to Diabetes Care |
IGF-1(insulin-like growth factor 1) |
Nanotechnology in Diabetes Treatment |
Neuroendocrinology and Pituitary |
Nutrition and Metabolism |
Obesity and Appetite Regulation |
Pediatric Endocrinology |
Pituitary Research and Growth Disorders |
Pituitary Research and Growth Disorders |
Reproductive Endocrinology |
Steroid Hormones and Receptors |
Thyroid Disorders and Cancer |
Transgender Medicine and Research |